Business Description
Cryofocus Medtech (Shanghai) Co Ltd
ISIN : CNE100005MV5
Share Class Description:
HKSE:06922: Class HCompare
Compare
Traded in other countries / regions
06922.Hong Kong IPO Date
2022-12-30Description
Cryofocus Medtech (Shanghai) Co Ltd is a medical device company engaged in the research and development, manufacture and sale of cryoablation minimally-invasive interventional treatment technology and related medical products. It has two Core Products, the Bladder Cryoablation System and the Endoscopic Clip for Anastomosis. The Bladder Cryoablation System is a cryotherapy device designed for the treatment of bladder cancer. The Endoscopic Clip for Anastomosis is an anastomotic device for the closure of soft tissue in the digestive tract, which is one of the over-the-scope clips. Geographically company's key revenue is generated from China.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 9.39 | |||||
Equity-to-Asset | 0.76 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | -0.11 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 18.53 | |||||
Beneish M-Score | 5.22 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 70.39 | |||||
9-Day RSI | 65.79 | |||||
14-Day RSI | 57.83 | |||||
6-1 Month Momentum % | -60.22 | |||||
12-1 Month Momentum % | -59.47 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.87 | |||||
Quick Ratio | 4.08 | |||||
Cash Ratio | 3.36 | |||||
Days Inventory | 858.72 | |||||
Days Sales Outstanding | 0.17 | |||||
Days Payable | 84.5 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -0.04 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 75.83 | |||||
Operating Margin % | -263.12 | |||||
Net Margin % | -238.06 | |||||
FCF Margin % | -300.71 | |||||
ROE % | -47.86 | |||||
ROA % | -37.02 | |||||
ROIC % | -145.6 | |||||
ROC (Joel Greenblatt) % | -205.15 | |||||
ROCE % | -45.93 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 42.5 | |||||
PB Ratio | 10.8 | |||||
Price-to-Tangible-Book | 10.8 | |||||
EV-to-EBIT | -15.78 | |||||
EV-to-EBITDA | -16.46 | |||||
EV-to-Revenue | 40.49 | |||||
EV-to-FCF | -13.46 | |||||
Price-to-Net-Current-Asset-Value | 17.76 | |||||
Price-to-Net-Cash | 33.29 | |||||
Earnings Yield (Greenblatt) % | -6.34 | |||||
FCF Yield % | -7.05 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cryofocus Medtech (Shanghai) Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 44.791 | ||
EPS (TTM) (HK$) | -0.449 | ||
Beta | 0 | ||
Volatility % | 76.22 | ||
14-Day RSI | 57.83 | ||
14-Day ATR (HK$) | 0.19021 | ||
20-Day SMA (HK$) | 7.5375 | ||
12-1 Month Momentum % | -59.47 | ||
52-Week Range (HK$) | 5 - 19.5 | ||
Shares Outstanding (Mil) | 239.11 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cryofocus Medtech (Shanghai) Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Cryofocus Medtech (Shanghai) Co Ltd Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
Cryofocus Medtech (Shanghai) Co Ltd Frequently Asked Questions
What is Cryofocus Medtech (Shanghai) Co Ltd(HKSE:06922)'s stock price today?
The current price of HKSE:06922 is HK$7.99. The 52 week high of HKSE:06922 is HK$19.50 and 52 week low is HK$5.00.
When is next earnings date of Cryofocus Medtech (Shanghai) Co Ltd(HKSE:06922)?
The next earnings date of Cryofocus Medtech (Shanghai) Co Ltd(HKSE:06922) is .
Does Cryofocus Medtech (Shanghai) Co Ltd(HKSE:06922) pay dividends? If so, how much?
Cryofocus Medtech (Shanghai) Co Ltd(HKSE:06922) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |